98 results
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
of ACAM Vaccine. (ANNUALLY for record retention) 3. ACAM Vaccine lots in inventory, number of vials, and quantity in quarantine. (ANNUALLY for over
8-K
EBS
Emergent Biosolutions Inc
26 Apr 24
Departure of Directors or Certain Officers
4:30pm
in July 2023.
Pursuant to the Amendments, the Company will pay an additional retention bonus of $399,753 to Mr. Lindahl, $380,250 to Ms. Fox, $373,761 … to Ms. Glessner and $292,501 to Mr. Williams (together, the “Additional Retention Bonuses”). The Additional Retention Bonuses are payable on or before
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
26 Apr 24
Departure of Directors or Certain Officers
4:30pm
WEIL:\99660008\5\43717.0003 April [ ], 2024 NAME ADDRESS Via Email: XXX@ebsi.com RE: Amendment to Key Employee Retention Program Dear … [ ]: In recognition of your continuing key role at Emergent BioSolutions Inc. (the "Company"), you and the Company entered into a Key Employee Retention Program
8-K
yyibw1h3
27 Jul 23
Departure of Directors or Certain Officers
4:48pm
8-K
EX-10.1
1kv mt8q0ve3qgx
17 May 23
Emergent’s Statement Regarding its Amended Credit Agreement
9:32pm
DEFR14A
91pwf ujkra
24 Apr 23
Revised proxy
9:32am
8-K
EX-2
9brryae9sd
18 May 22
Entry into a Material Definitive Agreement
5:13pm
8-K
mzy5ximnyetb3i 5fye7
22 Feb 22
Departure of Directors or Certain Officers
4:11pm
8-K/A
EX-10.1
pa1u4sjqj0qg hd
9 Sep 21
Financial Statements and Exhibits
4:33pm